• Annexin V-APC/7-AAD in Translational Cell Death Research

  2026-10-03

  A thought-leadership analysis of how dual-parameter cell-death profiling can strengthen translational interpretation of PAD4 and NET-focused cancer research.

• Meropenem Workflows for Resistance Research

  2026-10-02

  Build reproducible Meropenem MIC, time-kill, resistance-selection, and delivery assays with practical controls for β-lactam stability. This guide translates PK/PD lessons from ceftolozane/tazobactam research into research-use-only workflows for Gram-negative and Gram-positive models.

• E. coli Uracil-DNA Glycosylase (UDG) Guide

  2026-10-01

  K1107 is a recombinant E. coli Uracil-DNA Glycosylase for excising uracil from single- and double-stranded DNA, supporting PCR product contamination elimination and related DNA repair workflows. It is not intended for RNA, oligonucleotides shorter than six bases, or diagnostic and medical applications.

• Tropifexor (LJN452) in Reliable Cell Assays

  2026-10-01

  Learn how Tropifexor (LJN452), SKU BA3602, can improve the design and interpretation of FXR-focused viability, proliferation, and intestinal barrier experiments. This scenario-based guide covers formulation, controls, assay compatibility, vendor selection, and evidence limits for biomedical research.

• ALC-0315: From Lipid Choice to Escape Strategy

  2026-09-30

  ALC-0315 is best evaluated as a controllable element of an LNP system, not as a standalone delivery solution. This translational guide connects its ionizable-lipid mechanism and practical handling requirements with emerging in vivo evidence that endosomal escape—not simply nanoparticle uptake—is a decisive bottleneck in therapeutic mRNA delivery.

• 3X FLAG Peptide: Evidence-Based Workflow Guide

  2026-09-30

  The 3X (DYKDDDDK) Peptide is a 23-residue hydrophilic FLAG epitope reagent for affinity purification, immunodetection, and structural workflows. Its defined solubility, storage, and metal-sensitive antibody-binding properties support reproducible assay planning when interpreted with appropriate controls.

• AMG 9810: TRPV1 Antagonist Workflow Guide

  2026-09-29

  Use AMG 9810 to separate TRPV1-dependent calcium entry and CGRP secretion from broader metabolic-stress effects in sensory neuron experiments. This practical guide covers solvent handling, concentration-response design, assay controls, and a cautious framework for connecting nociceptive signaling with the AMPK–SQSTM1 stress-response axis.

• ALC-0315: Practical LNP Formulation Guide

  2026-09-29

  ALC-0315 is an ionizable amino lipid used to develop lipid nanoparticles for nucleic acid drug delivery, including mRNA workflows. It is an organic-solvent-soluble, water-insoluble formulation component and should not be treated as a validated clinical composition or a standalone aqueous reagent.

• Cefoperazone Sodium Salt Assay Workflows

  2026-09-28

  Build reproducible MIC, MBC, β-lactamase-resistance, and bile-relevant experiments with Cefoperazone sodium salt. This guide combines a reference-style broth workflow with practical formulation, comparison, and troubleshooting strategies for gram-negative bacterial research.

• PPACK Dihydrochloride: Mechanism and Research Use

  2026-09-28

  PPACK Dihydrochloride is an irreversible inhibitor of human α-thrombin, with a product-reported inhibition constant (Ki) of 0.24 nM. D-Phenylalanyl-L-prolyl-L-arginine chloromethyl ketone supports experimental control of thrombin activity, but it should not be treated as a blocker of platelet P2 receptors.

• ALC-0315: LNP Formulation and Evidence

  2026-09-27

  ALC-0315 is an ionizable amino lipid used in lipid nanoparticle research for nucleic acid drug delivery. Its product specifications describe identity, purity, solubility, and storage, while a 2026 study shows that mixing conditions can change LNP properties and biological performance independently of lipid choice.

• ATRX Loss and RTK Inhibitor Sensitivity in Glioma

  2026-09-26

  ATRX loss may help explain why some high-grade glioma cells respond differently to receptor tyrosine kinase inhibitors. This article examines the study behind that hypothesis, outlines a rigorous validation strategy, and considers how to evaluate AZ 10417808 in a biomarker-aware research workflow without assuming an unverified target profile.

• Clozapine N-oxide in Circadian Circuit Research

  2026-09-25

  Clozapine N-oxide (CNO) can help researchers test how defined neuronal populations contribute to circadian responses. This article connects chemogenetic perturbation to time-restricted feeding findings and explains the controls needed to distinguish acute circuit effects from lasting behavioral aftereffects.

• SARS-CoV-2 NSP15 Screening: Thymopentin and Oleuropein

  2026-09-25

  A 2021 structure-based virtual screen nominated thymopentin and oleuropein as promising binders of the SARS-CoV-2 endoribonuclease NSP15, with molecular-dynamics simulations supporting the stability of the modeled complexes. The findings provide computational leads for experimental testing, not evidence that either compound inhibits NSP15 or treats COVID-19 in patients.

• Rhodamine B as an Assay Design Tool in Cell Biology

  2026-09-24

  Rhodamine B is more than a visible label: its value in microscopy depends on separating fluorescence readout from biological mechanism. This article connects practical dye selection to a trypsin-responsive pancreatitis nanomedicine study—and explains what that study does, and does not, establish for fluorescence assays.

7652 records 1/511 page Next 12345 下5页 Last page